In Canada, the forecasted leukemia mortality rate from 2024 to 2028 shows a gradual increase from 2.91 to 2.99 thousand deaths. In 2023, the recorded mortality was slightly lower, establishing a consistent, albeit modest, upward trend over these years. The yearly increase in leukemia-related deaths suggests slight but steady growth, with each year's percentage increase marginally moving up. The compound annual growth rate (CAGR) over this five-year period underscores an average escalation in mortality rates, highlighting efficient areas for intervention and healthcare advancements.
Future trends to watch include the impact of emerging therapies and technologies in cancer treatment, accessibility to healthcare services, and the aging population's role in these mortality rates. Monitoring these factors will be essential for strategic planning in public healthcare initiatives.
